Last reviewed · How we verify
Saw palmetto and sanmiaoshan capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Saw palmetto and sanmiaoshan capsule (Saw palmetto and sanmiaoshan capsule) — Hospital Authority, Hong Kong.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Saw palmetto and sanmiaoshan capsule TARGET | Saw palmetto and sanmiaoshan capsule | Hospital Authority, Hong Kong | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Saw palmetto and sanmiaoshan capsule CI watch — RSS
- Saw palmetto and sanmiaoshan capsule CI watch — Atom
- Saw palmetto and sanmiaoshan capsule CI watch — JSON
- Saw palmetto and sanmiaoshan capsule alone — RSS
Cite this brief
Drug Landscape (2026). Saw palmetto and sanmiaoshan capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/saw-palmetto-and-sanmiaoshan-capsule. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab